The Sanders Tri-Institutional Therapeutics Discovery Institute Inc, affiliated with Weill Cornell, is a nonprofit organization dedicated to advancing medical research and public health, with a focus on improving the diagnosis, prevention, and treatment of diseases. With an operating budget of $16.6 million for the 2024 filing year, the organization engages in critical work within the fields of chemistry and pharmacology. More information about their initiatives can be found on their website, www.tritdi.org.